Intralesional Rituximab for the Treatment of Recurrent Ocular Adnexal Lymphoma.

Demirci, Hakan; Kauh, Courtney Y; Rajaii, Fatemeh; Elner, Victor M

Demirci, Hakan; Kauh, Courtney Y; Rajaii, Fatemeh; Elner, Victor M.

Affiliation

Demirci H; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, U.S.A.

Ophthalmic Plast Reconstr Surg ; 33(3S Suppl 1): S70-S71, 2017.

Article in En | MEDLINE | ID: mdl-26950471

Subject(s)

Eye Neoplasms/drug therapy; Lacrimal Apparatus Diseases/drug therapy; Lacrimal Apparatus/diagnostic imaging; Lymphoma, B-Cell, Marginal Zone/drug therapy; Neoplasm Recurrence, Local/drug therapy; Rituximab/administration & dosage; Adolescent; Antineoplastic Agents/administration & dosage; Biopsy; Eye Neoplasms/diagnosis; Female; Follow-Up Studies; Humans; Injections, Intralesional; Lacrimal Apparatus Diseases/diagnosis; Lymphoma, B-Cell, Marginal Zone/diagnosis; Neoplasm Recurrence, Local/diagnosis; Tomography, X-Ray Computed

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell, Marginal Zone / Eye Neoplasms / Rituximab / Lacrimal Apparatus / Lacrimal Apparatus Diseases / Neoplasm Recurrence, Local Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Female / Humans Language: En Journal: Ophthalmic Plast Reconstr Surg Journal subject: OFTALMOLOGIA Year: 2017 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google